CDC Announced Expansion of Megellan Diagnostic’s Recall

COLA Inc. is engaged with the CDC’s Laboratory Outreach Communication System (LOCS) in the Division of Laboratory Systems (DLS) to transmit their public health messages to our laboratories and affiliates. There are several important announcements for the month of October. You can find more details by clicking on the links below: 

On October 18, 2021, the CDC announced the expansion of the Megellan Diagnostic’s recall of LeadCare II, LeadCare Plus, and LeadCare Ultra Blood Lead Tests, which were distributed from October 27, 2020 to August 19, 2021. Additional LeadCare II product lots, including lots previously reported to be unaffected, were recalled due to a significant risk of falsely low results.